Allergy Therapeutics plc (AGYTF)

Allergy Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 21, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	878	519	316	9	162	222
Market Cap Growth	111.81%	64.47%	3383.37%	-94.42%	-26.72%	100.94%
Enterprise Value	943	550	311	2	124	171
Last Close Price	0.11	0.09	0.02	0.17	0.27	0.23
PE Ratio	-	-	-	-	-	55.59
PS Ratio	11.65	6.88	4.53	0.12	1.84	1.90
PB Ratio	-22.74	-13.44	33.95	3.45	3.54	3.31
P/TBV Ratio	-	-	93.58	-	4.08	3.67
P/FCF Ratio	-	-	-	-	-	26.62
P/OCF Ratio	-	-	-	-	-	18.68
EV/Sales Ratio	12.57	7.30	4.46	0.03	1.40	1.47
EV/EBITDA Ratio	-	-	-	-	-	20.31
EV/EBIT Ratio	-	-	-	-	-	31.62
EV/FCF Ratio	-21.94	-	-	-	-	20.60
Debt / Equity Ratio	-2.13	-2.13	4.21	17.42	0.28	0.23
Debt / EBITDA Ratio	-	-	-	-	-	1.44
Debt / FCF Ratio	-	-	-	-	-	1.85
Asset Turnover	0.82	0.82	0.83	0.85	0.90	0.97
Inventory Turnover	1.93	1.93	2.09	2.29	2.09	2.11
Quick Ratio	0.69	0.69	1.02	1.07	1.46	2.46
Current Ratio	1.27	1.27	1.78	1.81	2.35	3.17
Return on Equity (ROE)	-	-	-819.81%	-216.27%	-31.93%	6.25%
Return on Assets (ROA)	-26.58%	-26.58%	-32.23%	-31.48%	-9.60%	2.81%
Return on Invested Capital (ROIC)	-149.09%	-127.92%	-141.18%	-138.02%	-52.41%	16.12%
Return on Capital Employed (ROCE)	-70.60%	-70.60%	-72.10%	-73.00%	-22.50%	5.60%
Earnings Yield	-6.26%	-10.59%	-15.46%	-604.03%	-10.31%	1.80%
FCF Yield	-4.89%	-8.28%	-14.23%	-470.51%	-12.76%	3.76%
Buyback Yield / Dilution	-27.33%	-27.33%	-458.41%	-4.26%	4.98%	-0.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.